TMCO1 and open-angle glaucoma: Decreased expression of TMCO1 and increased expression of RP11-466F5.8 are proposed to lead to increased IOP levels and increased POAG risk (Fig. 4, Supplementary Fig. 6, and Supplementary Data 13).